Dr. SCOTUS Will Now See Your Next Patient
Osimertinib Yields 'Phenomenal' Gains in PFS for Stage III EGFR-Mutant NSCLC
Surgeon General: Americans Have Accepted Fear of Gun Violence as 'Normal'
Surgeon General: Vaping May Be an 'Attractive' Smoking Cessation Tool for Adults
Growing Evidence of 'Harm' From Social Media, Says Surgeon General
Experts Discuss the Latest Studies on ADCs for Lung Cancer at ASCO 2024
Highlights in Metastatic Breast Cancer: Key Findings From ASCO 2024
Experts Discuss Breakthroughs in Large B-Cell Lymphoma at ASCO Annual Meeting
Combination of Pembro and Liposomal Gemcitabine Shows Safety in Solid Tumor Patients
Olaparib Shows 'Unbelievable' Response Rate in MBC With PALB2 or BRCA Mutations
'Very Clear Signal' That Survival Improved With Addition of Durvalumab in SCLC
Belantamab Mafodotin: The Comeback Drug in Multiple Myeloma
TIL Therapy May Offer Novel Approach for Metastatic Lung Cancer
Experts Discuss Groundbreaking Advances in EGFR-Mutant Lung Cancer
Study Supports Continued Use of CDK4/6 Inhibitors in Advanced Breast Cancer
Pivotal Studies in Double-Expressor DLBCL Yield Divergent Results
Novel IL-2 Agent Shows Promise in Advanced Solid Tumors
Ribociclib Reduces Risk of Recurrence for High-Risk Node-Negative Breast Cancer
Advances in Immunotherapy for Prostate Cancer: Key Findings From ASCO 2024
The Promise of Bacteriophage Therapy to Fight Drug-Resistant Superbugs
Climate Change and Its Negative Effects on Lung Health
CAR T-Cell Therapy in Functional High-Risk Multiple Myeloma
In CROWN, Lorlatinib Shows Longest PFS in ALK-Positive Lung Cancer
TNBC: Distinct Tumor Immune Microenvironments at Metastatic Sites
